I'm always suspect of people who either promote or suggest shorting any stock. I can see why they might share that with their clients but why would they share with the general public? I truly don't care what analyst think but since others do I do follow recommendations. Not because I value their judgment but because other investors may.
Not sure we reach 128 by earnings but you were right on Gild and the larger biotechs (Biib and Gild leading the way higher for the IBB).
the trend is your friend with biotech, that is certain.
Based on my experience, we just dont fight against GS ever
no matter how much you hate their recommendations or in/out
of their conviction list of buy or sell any stock = lesson should be learned
=== So You Want to Be a Short Seller... -- Barron's Blog
21 hours 16 minutes ago - DJNF
By Ben Levisohn
Back in my trading days, we used to say that a stock could be too expensive to buy but never too cheap to sell, which was one of the things that made short selling so attractive. In a report released yesterday, Goldman Sachs offers a framework for short selling--and a few stocks that could soon be feeling gravity's pull, including Celgene ( CELG), O'Reilly Automotive ( ORLY), and Equity Residential ( EQR).
They said to short it when it was $22 few yrs back and they put sell on it at $70 lol. Are you gonna listen to them or are you gonna buy a stock trading at forward PE 18, with guidance for the next 5 yrs.
best biotech stock on the market with future guidance for the next yr and 7 billion in cash. You will be kicking yourself for not buying at 115 in few weeks when its at 125 again.
Tough to short Celg when price targets are $162.00. It may go down to its 200 day average at $105.00. That is the cap. The IBB tracks Celg if it goes down to $230.00 you will have your $105.00. Too much money to made here before earnings.
Investors that let the likes of a Goldman scam you out of your stock shouldn't own stock ever. Valuations rise and fall with a companies growth and Free Cash Flow. CELG has both. Its options expiration week and GS is doing all they can including releasing and re-releasing the same piece for 2 weeks now. What a joke. Look at their track record. Their own hedge fund has done LOUSY for clients and they typically only make money for themselves. If you're long term minded and don't need the money today, just wait. CELG will continue to rise with fits and starts for MANY more years.
I am trying to recall a time when listening to GS was the right thing to do. Nope!, cant think of one. Buy CELG.